Ticker Details
Kiniksa Pharmaceuticals, Ltd.
IPO Date:	May 21, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.98B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.56 | 2.91%
Avg Daily Range (30 D):	$1.59 | 2.81%
Avg Daily Range (90 D):	$1.36 | 2.65%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.58M
Avg Daily Volume (90 D):	.58M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	53
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	1,975
Avg Institutional Trade:	$2.01M
Avg Institutional Trade (30 D):	$6.87M
Avg Institutional Trade (90 D):	$3.57M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.19M
Avg Closing Trade (30 D):	$13.05M
Avg Closing Trade (90 D):	$7.19M
Avg Closing Volume:	87.12K

News

Apr 28, 2026 @ 11:10 PM Why Kiniksa Pharmaceuticals International Stock Ra... Source: Eric Volkman

Oct 17, 2025 @ 12:00 PM Kiniksa Pharmaceuticals Announces U.S. Orphan Drug... Source: Kiniksa Pharmaceuticals International

Jun 5, 2025 @ 11:00 AM Kiniksa Pharmaceuticals Announces Trial Design of ... Source: N/A

May 29, 2025 @ 8:01 PM Kiniksa Pharmaceuticals to Present at Upcoming Inv... Source: N/A

Mar 14, 2025 @ 9:51 AM 3 No-Brainer Healthcare Stocks to Buy With $1,000 ... Source: Keith Speights

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.98	$.3	$.19
Diluted EPS	$.91	$.27	$.18
Revenue	$754.05M	$214.27M	$202.13M
Gross Profit	$673.44M	$193.47M	$181.18M
Net Income / Loss	$73.06M	$22.59M	$14.2M
Operating Income / Loss	$93.22M	$29.27M	$19.77M
Cost of Revenue	$80.6M	$20.8M	$20.95M
Net Cash Flow	$32.82M	$24.36M	$-9.26M
PE Ratio